NCT01469065
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Chula Vista, California, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site Hachioji-shi, Tokyo, Japan